In addition, severe liver fibrosis did not result in a significant change in liver HIF-2α transcription levels in patients with alcoholic-related liver disease, chronic HBV-related liver disease, chronic HCV-related liver disease, and nonalcoholic fatty liver disease (Figs. 5B–5E). The gene discussed is EPAS1; the disease is metabolic dysfunction-associated steatotic liver disease.